Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
RVNC - As of  05/21/24, 05:22:13 AM:   19 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$13.25  Avg Vol(3m): 303,200  P/E: 0.00  EPS: -3.07

Email this page to a friend.    Insider Transactions for RVNC

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-08-10 09:43:11.0 Revance Therapeutics RVNC BlackRock Inc 7.2% view
S 2020-01-17 10:33:17.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 11.44% view
S 2019-11-12 11:27:57.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 4.81% view
S 2019-02-14 07:53:43.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 9.04% view
B 2019-02-12 11:36:23.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 11.66% view
B 2019-02-06 17:28:18.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 6.89% view
B 2019-01-28 15:40:35.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 10.2% view
S 2018-04-10 11:03:12.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 10.52% view
B 2018-02-09 09:37:06.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 9.84% view
S 2018-02-07 15:10:34.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 5.9% view
B 2018-01-25 14:09:56.0 Revance Therapeutics RVNC BlackRock Inc 7.1% view
S 2017-02-09 13:19:19.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 10.9% view
B 2017-02-03 12:50:47.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 7.1% view
B 2017-01-11 12:49:32.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 16.4% view
S 2016-02-10 13:40:28.0 Revance Therapeutics RVNC NovaQuest Pharma Opportunities Fund III 11.1% view
B 2016-01-28 15:59:50.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 7.16% view
B 2016-01-21 16:54:02.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 10.4% view
S 2015-02-17 07:53:29.0 Revance Therapeutics RVNC Visium Asset Management 4.2% view
B 2015-01-09 13:09:19.0 Revance Therapeutics n/a Visium Asset Management 6.1% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.